Trials commence at Papworth for lung isolation device

NHS Innovations East was set up to help NHS staff in the region develop new ideas that will enhance healthcare delivery. One of the latest innovations to emerge is a new device designed to improve patient safety in lung isolation for thoracic surgery.

Clinical trials have now commenced at Papworth Hospital and an exclusive deal has been signed with Phoenix Medical, a P3 Medical company, for the commercial rights to the “Papworth BiVent Endotracheal tube”.

Compared to other techniques, positioning within the appropriate bronchus is claimed to be easier and less time consuming. More importantly, the bifurcated tip design stabilises the inflated “blocker cuff” (the device that isolates the lung), preventing herniation into the trachea or dislodgement from the bronchial orifice. This reduces the risk of displacement when moving the patient, or during surgical handling of the lungs, thereby improving patient safety.

Latest Issues

VyvaExperts25

Virtual
30th - 31st October 2025

AfPP Regional Conference – Edinburgh

John McIntyre Conference Centre, The University of Edinburgh
22nd November 2025

IDSc Annual Congress 2025

Hilton Birmingham Metropole
24th - 26th November 2025